Screener
BMED vs PPH
iShares Health Innovation Active ETF vs VanEck Pharmaceutical ETF
Key differences
- PPH costs 0.19% less per year.
- PPH is significantly larger than BMED — larger funds tend to be more liquid and less likely to close.
- BMED follows a active selection strategy; PPH uses index tracking.
- Over the last 3 years, PPH has delivered higher annualized returns.
- PPH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BMED | PPH | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.36% |
| Fund size (AUM) | $10M | $966M |
| Since | 2020 | 2011 |
| Dividend yield | 0.00% | 2.12% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | +18.7% | +24.2% |
| CAGR 3Y | +4.8% | +12.4% |
| CAGR 5Y | +0.1% | +9.9% |
| Sharpe 3Y | 0.16 | 0.61 |
| Volatility 1Y | 14.93% | 17.11% |
| Max drawdown | -36.44% | -29.70% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BMED and PPH
Explore further